INSIDE THE CLASSICAL MODEL · OPERATING RESPONSIBILITIES
DGCL § 141(a) and TBOC § 21.401 vest “the business and affairs” in the board. That delegation resolves into six recurring categories of decision, each disciplined by a distinct legal mechanism — the business-judgment rule, entire fairness, a federal disclosure mandate, or a Caremark-style monitoring duty.
Read this section
1. CEO selection, oversight, and removal
The DGCL commits day-to-day management to officers appointed by the board1 and authorizes the board to remove them with or without cause.2 Officers owe the same fiduciary duties of care and loyalty as directors.3 The board’s hiring, evaluation, and removal of the CEO are themselves fiduciary acts — reviewable under the business-judgment rule when the board is disinterested and reasonably informed,4 and under entire fairness when a controller is on the other side.5 The NYSE and Nasdaq listing standards require that non-management directors meet in regular executive session without the CEO present,6 and that boards adopt and disclose corporate-governance guidelines covering an annual board evaluation.7
2. Executive compensation, clawback, and succession
Executive pay sits at a federal-state seam. Substantive authority sits with the board (or its compensation committee) under DGCL § 122(15) and § 157,8 but disclosure, voting, and recovery are federal. Item 402 of Regulation S-K requires Compensation Discussion & Analysis and the Summary Compensation Table.9 Dodd-Frank § 951 mandates a non-binding say-on-pay vote at least once every three years;10 § 953(b) requires CEO pay-ratio disclosure;11 § 954, implemented by SEC Rule 10D-1, requires recovery of incentive compensation paid on the basis of erroneously reported financial information.12 The compensation committee must be composed of independent directors under SEC Rule 10C-1, with heightened independence factors for any compensation consultant it retains.13 Succession planning is not separately mandated by statute, but the Court of Chancery treats it as part of the board’s Caremark oversight where the absence of a credible succession plan would itself be a mission-critical failure.14
3. Approval of corporate purpose, strategy, plans, and budgets
The board’s authority over corporate strategy flows from DGCL § 141(a) and TBOC § 21.401 and is exercised under the business-judgment rule absent a disabling conflict. On an ordinary day, directors of a for-profit corporation may consider stakeholders so long as the consideration is rationally tied to long-term stockholder welfare; in Revlon mode — sale of control or breakup — that latitude narrows to seeking the best transaction reasonably available.15 Mergers, charter amendments, asset sales, and dissolution additionally require a stockholder vote;16 the board must satisfy itself that any such transaction is properly submitted and that its own informational and procedural posture supports the recommendation.17
4. Oversight of financial reporting and internal controls
Sarbanes-Oxley § 302 requires the CEO and CFO to certify each periodic report;18 § 404 requires management to assess, and the external auditor to audit, the issuer’s internal control over financial reporting (ICFR).19 The PCAOB’s Auditing Standard 2201 governs the ICFR audit;20 AS 1301 governs the auditor’s required communications with the audit committee.21 SEC Rule 10A-3 requires that the audit committee be composed entirely of independent directors and be directly responsible for the appointment, compensation, retention, and oversight of the external auditor.22 Item 407(d)(5) of Regulation S-K requires that at least one audit-committee member be disclosed as an SEC-defined “audit committee financial expert” or that the issuer disclose why not.23
5. Oversight of capital structure and capital allocation
Stock issuance, repurchases, and dividends are statutory board decisions. DGCL §§ 151–153 govern share authorization; § 160 governs the corporation’s purchase of its own shares; § 170 limits dividends to surplus or net profits.24 Capital-allocation decisions are reviewed under the business-judgment rule when the board is disinterested, but heightened review applies when a controller is differentially affected — as in In re Trados Inc. S’holder Litig., where the Court of Chancery applied entire fairness to a transaction that paid common stockholders nothing while satisfying the controlling preferred holders’ liquidation preferences.25
6. Oversight of risk — the Caremark perimeter
The doctrinal foundation is the four-case trajectory developed in the preceding callout: Caremark created the board-level monitoring duty;26 Stone v. Ritter set bad faith as the liability standard;27 Marchand v. Barnhill revived the doctrine for mission-critical risk;28 and In re McDonald’s extended it to officers within their areas of responsibility.29 Cybersecurity is now an enumerated disclosure topic: Regulation S-K Item 106, effective September 5, 2023, requires issuers to describe board oversight of cybersecurity risk and the management positions and committees responsible.30 Form 8-K Item 1.05 requires four-business-day disclosure of any material cybersecurity incident.31
- 8 Del. C. § 142(a).
- 8 Del. C. § 142(b).
- Gantler v. Stephens, 965 A.2d 695, 708–09 (Del. 2009) (en banc).
- Aronson v. Lewis, 473 A.2d 805, 812 (Del. 1984).
- Weinberger v. UOP, Inc., 457 A.2d 701, 710–11 (Del. 1983).
- NYSE Listed Company Manual § 303A.03 (executive sessions of non-management directors).
- NYSE Listed Company Manual § 303A.09 (corporate-governance guidelines including annual evaluation).
- 8 Del. C. § 122(15); 8 Del. C. § 157 (stock options).
- 17 C.F.R. § 229.402.
- Dodd-Frank Act § 951; 15 U.S.C. § 78n-1.
- Dodd-Frank Act § 953(b); 17 C.F.R. § 229.402(u).
- Dodd-Frank Act § 954; SEC Rule 10D-1, 17 C.F.R. § 240.10D-1; implementing standards at NYSE § 303A.14 and Nasdaq Rule 5608.
- Exchange Act § 10C, 15 U.S.C. § 78j-3 (added by Dodd-Frank § 952); SEC Rule 10C-1, 17 C.F.R. § 240.10C-1; NYSE § 303A.05; Nasdaq Rule 5605(d).
- In re Caremark Int’l Inc. Deriv. Litig., 698 A.2d 959, 970–71 (Del. Ch. 1996); Marchand v. Barnhill, 212 A.3d 805 (Del. 2019).
- Revlon, Inc. v. MacAndrews & Forbes Holdings, Inc., 506 A.2d 173 (Del. 1986).
- 8 Del. C. § 251 (mergers); § 271 (sale of assets); § 242 (charter amendments); § 275 (dissolution).
- Smith v. Van Gorkom, 488 A.2d 858 (Del. 1985).
- Sarbanes-Oxley Act § 302; 15 U.S.C. § 7241.
- Sarbanes-Oxley Act § 404; 15 U.S.C. § 7262.
- PCAOB Auditing Standard 2201.
- PCAOB Auditing Standard 1301.
- SEC Rule 10A-3, 17 C.F.R. § 240.10A-3.
- 17 C.F.R. § 229.407(d)(5).
- 8 Del. C. §§ 151–153, 160, 170.
- In re Trados Inc. S’holder Litig., 73 A.3d 17 (Del. Ch. 2013) (Laster, V.C.).
- In re Caremark, 698 A.2d at 970–71 (Allen, Ch.).
- Stone v. Ritter, 911 A.2d 362 (Del. 2006).
- Marchand v. Barnhill, 212 A.3d 805 (Del. 2019).
- In re McDonald’s Corp. S’holder Deriv. Litig., 289 A.3d 343 (Del. Ch. 2023).
- 17 C.F.R. § 229.106; Securities Act Release No. 33-11216 (July 26, 2023).
- Form 8-K Item 1.05.